The DOI matches its Crossref record.
Drugs, Devices, and the FDA: Part 2
Open accessAbstract
As with new drugs, the U.S. Food and Drug Administration's approval process is intended to provide consumers with assurance that, once it reaches the market place, a medical device is safe and effective in its intended use. Bringing a device to market takes an average of 3 to 7 years, compared with an average of 12 years for drugs. However, there are concerns that Food and Drug Administration processes may not be sufficient to meet the assurances of safety and efficacy as intended. This second part of a 2-part series reviews the basic steps in development and Food and Drug Administration approval of medical devices, and summarizes post-marketing processes for drugs and devices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gao, Y., Peng, K., & Mitragotri, S. (2021) · Advanced Materials · doi:10.1002/adma.202006362 · Cited by 295
Van Norman, G. A. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.06.003 · Cited by 223
Self-citationMichelson, M., & Reuter, K. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100443 · Cited by 152
The promise of technology in the future of dementia care
Moyle, W. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0188-y · Cited by 130
Metadata
- Authors
- Van Norman, G. A.
- Venue
- JACC: Basic to Translational Science
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 1
- Issue
- 4
- Pages
- 277-287
- ISSN
- 2452-302X (ISSN-L)
- OpenAlex
- W2468144305
- Cited by
- 235
- References
- 0
- FWCI
- 18.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drugs, Devices, and the FDA: Part 2. https://app.cochat.ai/papers/10.1016/j.jacbts.2016.03.009
- The paper
- Van Norman, G. A. (2016). Drugs, Devices, and the FDA: Part 2. JACC: Basic to Translational Science. https://doi.org/10.1016/j.jacbts.2016.03.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.